Extended Delivery of Bupivacaine Study in Herniorrhaphy
Status:
Completed
Trial end date:
2018-10-26
Target enrollment:
Participant gender:
Summary
This is a phase 4, randomized, open-label study of the efficacy, safety, and pharmacokinetics
of bupivacaine administered as liposomal bupivacaine or continuous infusion via elastomeric
pump following unilateral open inguinal herniorrhaphy.